SCHEMBL2266822

SCHEMBL2266822

C/C=C/COC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21416131 1.00
SCHEMBL9911957 0.84 KDM4E (0.52)
SCHEMBL448049 0.83 ADRA2A (0.41)
SCHEMBL20528139 0.81 MGAM (0.46)
SCHEMBL6445001 0.80 MGAM (0.46)
SCHEMBL21467458 0.80 NAAA (0.38)
SCHEMBL6444996 0.80 MGAM (0.46)
SCHEMBL3892225 0.79
SCHEMBL7745837 0.79 TSHR (0.34)
SCHEMBL6552702 0.79 TSHR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106537145-B Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment 麦特博隆股份有限公司 2020-08-25 CN claimed
CN-113156096-A Blood-based biomarkers for diagnosing coronary atherosclerotic disease 全球基因集团有限责任公司 2021-07-23 CN disclosed
CN-112585116-A Synthesis of (2S, 3R, 4R) -4, 5-dihydroxyisoleucine and derivatives thereof 海德堡医药研究有限责任公司 2021-03-30 CN disclosed
CN-107427221-B Blood-based biomarkers for diagnosing coronary atherosclerotic disease 全球基因集团有限责任公司 2021-03-09 CN disclosed
US-7993931-B1 Oxygen-18 labeled organic acids and use in diagnosing metabolic disorders QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2011-08-09 US disclosed